XML 97 R41.htm IDEA: XBRL DOCUMENT v3.20.1
FAIR VALUE (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis
The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 and December 31, 2018 (in thousands):
 
December 31, 2019
 
Financial Statement Classification
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
 
 
Collegium warrants
 
Investments
 
$

 
$
9,629

 
$

 
$
9,629

Total
 
 
 
$

 
$
9,629

 
$

 
$
9,629

Liabilities:
 
 
 
 
 
 
 
 
 
 
Contingent consideration
 
Contingent consideration liability
 
$

 
$

 
$
168

 
$
168

Total
 
 
 
$

 
$

 
$
168

 
$
168



December 31, 2018
 
Financial Statement Classification
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
 
 
Money market funds
 
Cash and cash equivalents
 
$
11

 
$

 
$

 
$
11

Commercial paper
 
Cash and cash equivalents
 

 
14,028

 

 
14,028

Agency bond
 
Cash and cash equivalents
 

 
1,250

 

 
1,250

Collegium warrants
 
Investments
 

 
8,784

 

 
8,784

Total
 
 
 
$
11

 
$
24,062

 
$

 
$
24,073

Liabilities:
 
 
 
 
 
 
 
 
 
 
Contingent consideration
 
Contingent consideration liability
 
$

 
$

 
$
1,038

 
$
1,038

Total
 
 
 
$

 
$

 
$
1,038

 
$
1,038

Summary of the changes in fair value of all financial liabilities measured at fair value on a recurring basis using significant unobservable inputs
The table below provides a summary of the changes in fair value recorded in interest expense, selling, general and administrative expense, and gain on divestiture of Lazanda measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2019, 2018 and 2017 (in thousands):
 
 
December 31,
 
2019
 
2018
 
2017
Fair value, beginning of the period
$
1,038

 
$
1,613

 
$
14,825

Changes in fair value recorded in interest expense
113

 
124

 
1,079

Changes in fair value recorded in selling, general and administrative expenses
(983
)
 
(515
)
 
(7,708
)
Royalties and milestone paid

 
(184
)
 
(3,068
)
Divestiture of Lazanda

 

 
(3,515
)
Total
$
168

 
$
1,038

 
$
1,613